3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Colonic Neoplasms
3
Breast Neoplasms
2
Turcot syndrome
1
Stomach Neoplasms
1
Stereotactic Body Radiation Therapy
1
Rectal Neoplasms
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Neoplasm, Residual
1
NSCLC
1
Microsatellite Instability
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Bites and Stings
1
Interventions
Drug Therapy
3
Carboplatin
3
Surgical Procedures, Operative
2
Pemetrexed
2
Paclitaxel
2
Cisplatin
2
toripalimab
1
tislelizumab
1
surufatinib
1
osimertinib
1
lorlatinib
1
anlotinib
1
aflutinib
1
Radiotherapy
1
Radiosurgery
1
Platinum Compounds
1
Neoadjuvant Therapy
1
Diphenhydramine
1
Cryotherapy
1
Chemotherapy, Adjuvant
1
Chemoradiotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
NSCLC
×
Chemotherapy, Adjuvant
×
Clear all
NCT07089199
2025-07-28
TitAN
Qilu Hospital of Shandong University
Phase 2
Not yet recruiting
34 enrolled